Bpifrance backs LimFlow’s $33.5m series C round

The funding will be used to develop trials in the United States.

French medtech company LimFlow has this week announced the successful close of a series C round of funding worth €27m ($33.5m).

The round was led by Sofinnova Partners and featured returning investors Bpifrance, the French sovereign investment bank, and Singaporean fund Balestier.

See more from this Government Report: France


Supporting articles

Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.